By contrast, there was a significantly negative correlation of the expression of CPS1 and PTPRB with resistance of HCC cells to antitumor drugs such as palbociclib, talazoparib, and bosutinib. The gene discussed is PTPRB; the disease is hepatocellular carcinoma.